Cargando…

Notch activation inhibits AML growth and survival: a potential therapeutic approach

Although aberrant Notch activation contributes to leukemogenesis in T cells, its role in acute myelogenous leukemia (AML) remains unclear. Here, we report that human AML samples have robust expression of Notch receptors; however, Notch receptor activation and expression of downstream Notch targets a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kannan, Sankaranarayanan, Sutphin, Robert M., Hall, Mandy G., Golfman, Leonard S., Fang, Wendy, Nolo, Riitta M., Akers, Lauren J., Hammitt, Richard A., McMurray, John S., Kornblau, Steven M., Melnick, Ari M., Figueroa, Maria E., Zweidler-McKay, Patrick A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570106/ https://www.ncbi.nlm.nih.gov/pubmed/23359069 http://dx.doi.org/10.1084/jem.20121527

Ejemplares similares

Targeting P-selectin blocks neuroblastoma growth
por: Nolo, Riitta, et al.
Publicado: (2017)

Characterization of TRKA signaling in acute myeloid leukemia
por: Herbrich, Shelley M., et al.
Publicado: (2018)

Regulation of NOTCH Signaling by Reciprocal Inhibition of HES1 and Deltex 1 and its Role in Osteosarcoma Invasiveness
por: Zhang, Pingyu, et al.
Publicado: (2010)

The Challenge of Targeting Notch in Hematologic Malignancies
por: Hernandez Tejada, Fiorela N., et al.
Publicado: (2014)

Targeting the NRF2/HO-1 Antioxidant Pathway in FLT3-ITD-Positive AML Enhances Therapy Efficacy
por: Kannan, Sankaranarayan, et al.
Publicado: (2022)

Epigenetic Inactivation of Notch-Hes Pathway in Human B-Cell Acute Lymphoblastic Leukemia
por: Kuang, Shao-Qing, et al.
Publicado: (2013)

p53 pathway dysfunction in AML: beyond TP53 mutations
por: Post, Sean M., et al.
Publicado: (2017)

STAT activation status differentiates leukemogenic from non-leukemogenic stem cells in AML and is suppressed by arsenic in t(6;9)-positive AML
por: Oancea, Claudia, et al.
Publicado: (2014)

Notch pathway activation targets AML-initiating cell homeostasis and differentiation
por: Lobry, Camille, et al.
Publicado: (2013)

Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 Inhibitors
por: Ferrarotto, Renata, et al.
Publicado: (2017)

Signaling changes in the stem cell factor–AKT-S6 pathway in diagnostic AML samples are associated with disease relapse
por: Kornblau, S M, et al.
Publicado: (2011)

MLN0128, a novel mTOR kinase inhibitor, disrupts survival signaling and triggers apoptosis in AML and AML stem/ progenitor cells
por: Zeng, Zhihong, et al.
Publicado: (2016)

PRKD2 Promotes Progression and Chemoresistance of AML via Regulating Notch1 Pathway
por: Liu, Qian, et al.
Publicado: (2019)

The homeobox gene DLX4 regulates erythro-megakaryocytic differentiation by stimulating IL-1β and NF-κB signaling
por: Trinh, Bon Q., et al.
Publicado: (2015)

A Crowdsourcing Approach to Developing and Assessing Prediction Algorithms for AML Prognosis
por: Noren, David P., et al.
Publicado: (2016)

LARGE-SCALE ISOLATION AND FRACTIONATION OF ORGANS OF DROSOPHILA MELANOGASTER LARVAE
por: Zweidler, Alfred, et al.
Publicado: (1971)

PB1888: TRIAL IN PROGRESS: PHASE 1B/2 STUDY OF PIVEKIMAB SUNIRINE (PVEK, IMGN632) IN COMBINATION WITH VENETOCLAX/AZACITIDINE OR MAGROLIMAB FOR PATIENTS WITH CD123-POSITIVE ACUTE MYELOID LEUKEMIA (AML)
por: Daver, Naval, et al.
Publicado: (2023)

SSBP2 is an in vivo tumor suppressor and regulator of LDB1 stability
por: Wang, Yang, et al.
Publicado: (2010)

MLL-Rearranged Acute Lymphoblastic Leukemias Activate BCL-2 through H3K79 Methylation and Are Sensitive to the BCL-2-Specific Antagonist ABT-199
por: Benito, Juliana M., et al.
Publicado: (2015)

A G-Protein Coupled Receptor and Macular Degeneration
por: Figueroa, Anna G., et al.
Publicado: (2020)

The sound of swearing: Are there universal patterns in profanity?
por: Lev-Ari, Shiri, et al.
Publicado: (2022)

A stable transcription factor complex nucleated by oligomeric AML1-ETO controls leukaemogenesis
por: Sun, Xiao-Jian, et al.
Publicado: (2013)

Superior efficacy of co-targeting GFI1/KDM1A and BRD4 against AML and post-MPN secondary AML cells
por: Fiskus, Warren, et al.
Publicado: (2021)

Maintenance Therapy in AML
por: Reville, Patrick K., et al.
Publicado: (2021)

The role of the proteasome in AML
por: Csizmar, C M, et al.
Publicado: (2016)

LGALS3 is connected to CD74 in a previously unknown protein network that is associated with poor survival in patients with AML
por: Ruvolo, Peter P., et al.
Publicado: (2019)

AML-343: Loss of H3K27 Methylation Identifies Poor Outcomes in Adult-Onset Acute Lymphoblastic and Myeloid Leukemia
por: Dijk, Anneke van, et al.
Publicado: (2020)

Generation of anti-Notch antibodies and their application in blocking Notch signalling in neural stem cells
por: Falk, Ronny, et al.
Publicado: (2012)

Combination Therapies Targeting Apoptosis in Paediatric AML: Understanding the Molecular Mechanisms of AML Treatments Using Phosphoproteomics
por: Ali, Ahlam A., et al.
Publicado: (2023)

Tables of dimensions, indices, and branching rules for representations of simple Lie algebras
por: McKay, Wendy G, et al.
Publicado: (1981)

Single-cell polyfunctional proteomics of CD4 cells from patients with AML predicts responses to anti–PD-1–based therapy
por: Abbas, Hussein A., et al.
Publicado: (2021)

Genotype-outcome correlations in pediatric AML: the impact of a monosomal karyotype in trial AML-BFM 2004
por: Rasche, M, et al.
Publicado: (2017)

Who Has Therapy-Related AML?
por: Gale, Robert Peter, et al.
Publicado: (2017)

Significance of NPM1 Gene Mutations in AML
por: Hindley, Andrew, et al.
Publicado: (2021)

Switch of the mutation type of the NPM1 gene in acute myeloid leukemia (AML): relapse or secondary AML?
por: Webersinke, G, et al.
Publicado: (2014)

Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1
por: Fiskus, Warren, et al.
Publicado: (2023)

CME in the Time of COVID-19: Educating Healthcare Professionals at the Point-of-care and Improving Performance Outcomes
por: Damaske, Janet, et al.
Publicado: (2020)

Including Patient Voices in Continuing Medical Education: One Provider’s Experience
por: McKay, Jennifer, et al.
Publicado: (2023)

Enhanced sensitivity to glucocorticoids in cytarabine-resistant AML
por: Malani, D, et al.
Publicado: (2017)

No Evidence That Music Training Benefits Speech Perception in Hearing-Impaired Listeners: A Systematic Review
por: McKay, Colette M.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rdh0qu0ns9o1oqr64khsl5u55a